5/2
02:07 pm
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
5/1
12:34 pm
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
5/1
11:59 am
GTHX
Rating for GTHX
Medium
Report
Rating for GTHX
5/1
11:59 am
GTHX
Rating for GTHX
Medium
Report
Rating for GTHX
4/12
08:01 am
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/12
05:58 am
GTHX
Rating for GTHX
Low
Report
Rating for GTHX
4/12
05:58 am
GTHX
Rating for GTHX
Low
Report
Rating for GTHX
2/28
05:12 pm
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
2/28
05:12 pm
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
2/28
12:14 pm
GTHX
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
2/28
11:43 am
GTHX
Rating for GTHX
Medium
Report
Rating for GTHX
2/28
11:43 am
GTHX
Rating for GTHX
Medium
Report
Rating for GTHX
2/13
08:25 am
GTHX
Rating for GTHX
High
Report
Rating for GTHX
2/13
08:25 am
GTHX
Rating for GTHX
High
Report
Rating for GTHX
2/13
07:01 am
GTHX
Rating for GTHX
High
Report
Rating for GTHX
2/13
07:01 am
GTHX
Rating for GTHX
High
Report
Rating for GTHX